See also this year's filing and all EDGAR filings for this company.
PDF Report 0001822462_2021_Foghorn_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001822462, Foghorn Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 190,687,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 19,528,000 |
| 3 | remainder_Assets | 45,379,000 |
| 4 | LiabilitiesCurrent | 18,846,000 |
| 5 | LiabilitiesNoncurrent | 90,561,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,246,000 |
| 9 | ResearchAndDevelopmentExpense | 57,715,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 430,000 |
| 12 | remainder_NetIncome | -269,000 |
| 13 | remainder_ComprehensiveNetIncome | -7,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 255,594,000 |
| 1 | Liabilities | 109,407,000 |
| 2 | Expenses | 68,961,000 |
| 3 | Revenues | 430,000 |
| 4 | StockholdersEquity | 146,187,000 |
| 5 | NetIncome | -68,800,000 |
| 6 | ComprehensiveNetIncome | -68,803,500 |
| 7 | BaseVar | 217,334,000 |
| 8 | EconomicCapitalRatio | 1.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
